The aim of this study was to determine whether the rate of endophthalmitis occurring after intravitreal anti-vascular endothelial growth factors (VEGF) is different for simultaneous bilateral injections and unilateral injections when all factors are kept constant. The gene discussed is VEGFA; the disease is endophthalmitis.